Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Aytu Biopharma (AYTU) over the last 16 years, with Sep 2025 value amounting to $66.0 million.

  • Aytu Biopharma's Total Current Liabilities rose 7.74% to $66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year increase of 7.74%. This contributed to the annual value of $63.1 million for FY2025, which is 1.34% up from last year.
  • Aytu Biopharma's Total Current Liabilities amounted to $66.0 million in Q3 2025, which was up 4.64% from $63.1 million recorded in Q2 2025.
  • Aytu Biopharma's 5-year Total Current Liabilities high stood at $109.4 million for Q2 2021, and its period low was $61.3 million during Q3 2024.
  • In the last 3 years, Aytu Biopharma's Total Current Liabilities had a median value of $65.5 million in 2023 and averaged $68.6 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 355.67% in 2021, then crashed by 41.12% in 2022.
  • Over the past 5 years, Aytu Biopharma's Total Current Liabilities (Quarterly) stood at $100.6 million in 2021, then plummeted by 33.23% to $67.2 million in 2022, then dropped by 4.41% to $64.2 million in 2023, then decreased by 0.22% to $64.0 million in 2024, then grew by 7.74% to $66.0 million in 2025.
  • Its Total Current Liabilities stands at $66.0 million for Q3 2025, versus $63.1 million for Q2 2025 and $70.7 million for Q1 2025.